Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grana

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
AIDS Research and Human Retroviruses|October 9, 2010
Short communication: contribution of the immunovirological state and traditional cardiovascular risk factors to low HDL-cholesterol in HIV patientsR Palacios, S Puerta, F Orihuela, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2008
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factorsLisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
Oncogene|October 14, 2000
Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathwaysE V Rusyn, E R Reynolds, H Shao, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 2005
Platelet activation in patients with colorectal cancerM G Sciulli, P Filabozzi, S Tacconelli, et al.
European Journal of Haematology|July 28, 2007
Pretargeted antibody-guided radioimmunotherapy in a child affected by resistant anaplastic large cell lymphomaGiuseppe Palumbo, Chiara M Grana, Francesca Cocca, et al.
Ecancermedicalscience|April 26, 2016
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerLaura L Travaini, Maria G Zampino, Marzia Colandrea, et al.
British Journal of Haematology|November 6, 2007
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomasPier F Ferrucci, Anna Vanazzi, Chiara M Grana, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2021
Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institutionG D Di Stasio, L Travascio, M Colandrea, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2011
Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II studyLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
AIDS Research and Human Retroviruses|October 9, 2010
Short communication: contribution of the immunovirological state and traditional cardiovascular risk factors to low HDL-cholesterol in HIV patientsR Palacios, S Puerta, F Orihuela, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2008
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factorsLisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
Oncogene|October 14, 2000
Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathwaysE V Rusyn, E R Reynolds, H Shao, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 2005
Platelet activation in patients with colorectal cancerM G Sciulli, P Filabozzi, S Tacconelli, et al.
European Journal of Haematology|July 28, 2007
Pretargeted antibody-guided radioimmunotherapy in a child affected by resistant anaplastic large cell lymphomaGiuseppe Palumbo, Chiara M Grana, Francesca Cocca, et al.
Ecancermedicalscience|April 26, 2016
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerLaura L Travaini, Maria G Zampino, Marzia Colandrea, et al.
British Journal of Haematology|November 6, 2007
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomasPier F Ferrucci, Anna Vanazzi, Chiara M Grana, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2021
Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institutionG D Di Stasio, L Travascio, M Colandrea, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2011
Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II studyLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
Pageof 7